Particle Therapy Market is expected to increase at a compound annual growth rate (CAGR) of 9.6% from 2025 to 2035
The particle therapy
market was estimated to be worth USD 2.5 billion in 2024 and is
expected to grow at a compound annual growth rate (CAGR) of 9.6% to reach USD
3.6 billion in 2035. Particle therapy lowers the harm to heathy tissue and
enhances the disease control. The market is associated with the healthcare
industry, which makes it a sustainable and expanding market.
One form of
external beam radiation used to treat malignant tumors is particle therapy,
which mostly uses proton beams. Particle therapy is also referred to more
scientifically as hadron therapy. In this therapy most particle beams radiation
is administered in a precise manner and has specific physical features, which
reduce the collateral damage to normal tissues. This trait is particularly
essential for tumors positioned near critical structures and not spreading to
other sections of the body.
Request For Free Sample Pages @ https://www.xresearch.biz/request-sample-pages/particle-therapy-market
GROWTH
DRIVERS
The rise in
prevalence of cancer globally is the key primary driver of the market towards
expansion. International Agency for Research on Cancer (IARC) 2022 report notes
that 20 million new cancer cases and 9.7 million deaths globally, with lung and
breast cancer being most common. Furthermore, it is anticipated that the number
of cancer cases will rise to 35 million by 2050, especially in low and medium
HDI nations, underscoring the necessity of better healthcare infrastructure and
access to affordable cancer services.
Additionally,
they obtained a USD 1.5 million initial investment from the Wisconsin Alumni
Research Foundation and a USD 20 million grant from the National Cancer
Institute. The rise in aging population is more incident to cancer where
American Cancer Society database indicates that 39.6% of women and 41.6% of men
are projected to have cancer over their lifetime. People 65 years of age and
older are diagnosed with about two-thirds of all new cases.
MARKET
SEGMENTATION:
· By
Therapy Type- proton therapy (cyclotron and synchrotrons), heavy-ion
therapy and hybrid particle therapy
· By
Room Configuration Type- single room and multi room
· By
Application- research and treatment
· By
Cancer Type- pediatric cancer, breast cancer, lung cancer, prostate cancer,
colorectal cancer, liver cancer and others
· By
Region- North America, Europe, Asia Pacific, Middle & Africa and
South America
Global
Key Players:
· IBA
Worldwide
· Varian
Medical Systems
· Hitachi
· Mevion
Medical Systems
· Optivus
Proton Therapy
· Sumitomo
Heavy Industries, Ltd.
· Danfysik
A/S
· Provision
Healthcare
· Other
Players
For More Information about this Report @
https://www.xresearch.biz/shop/particle-therapy-market
About Us: -
xResearch
is a market research and consulting organization that uses unique data, expert
analysis, and new technologies to create trusted intelligence on industries.
Our research is focused on delivering an informed and impartial view on
essential market data of industry, and it is primarily driven by an in-depth
study covering the following parameters: Market Sizing and Forecasting, Market
Segmentation, Competitive Analysis, Strategic Assessment and Business
Modelling.
Contact:
Company Name: xResearch
Contact Person: James Lin
Email: sales@xresearch.biz
Phone: +1 718-619-8140
Websites: https://www.xresearch.biz/

Comments
Post a Comment